BE865163A - Nouveaux derives de la taurine a activite neuro-musculaire renforcee - Google Patents

Nouveaux derives de la taurine a activite neuro-musculaire renforcee

Info

Publication number
BE865163A
BE865163A BE2056782A BE2056782A BE865163A BE 865163 A BE865163 A BE 865163A BE 2056782 A BE2056782 A BE 2056782A BE 2056782 A BE2056782 A BE 2056782A BE 865163 A BE865163 A BE 865163A
Authority
BE
Belgium
Prior art keywords
taurine
enhanced
new derivatives
neuromuscular activity
neuromuscular
Prior art date
Application number
BE2056782A
Other languages
English (en)
French (fr)
Inventor
J P Durlach
Original Assignee
Francaise Coop Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Francaise Coop Pharma filed Critical Francaise Coop Pharma
Publication of BE865163A publication Critical patent/BE865163A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/02—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof
    • C07C303/22—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof from sulfonic acids, by reactions not involving the formation of sulfo or halosulfonyl groups; from sulfonic halides by reactions not involving the formation of halosulfonyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
    • C07C309/15—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton the nitrogen atom of at least one of the amino groups being part of any of the groups, X being a hetero atom, Y being any atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE2056782A 1977-03-23 1978-03-22 Nouveaux derives de la taurine a activite neuro-musculaire renforcee BE865163A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7708692A FR2384751A1 (fr) 1977-03-23 1977-03-23 Nouveaux derives de la taurine a activite neuro-musculaire renforcee

Publications (1)

Publication Number Publication Date
BE865163A true BE865163A (fr) 1978-09-22

Family

ID=9188473

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2056782A BE865163A (fr) 1977-03-23 1978-03-22 Nouveaux derives de la taurine a activite neuro-musculaire renforcee

Country Status (17)

Country Link
US (3) US4199601A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS53149928A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT356637B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU523705B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE865163A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1095930A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH629479A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2810918C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES468201A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2384751A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1599962A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR62093B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1111455B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7803131A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
OA (1) OA05914A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE443781B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA781697B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2457281A1 (fr) 1979-05-23 1980-12-19 Meram Lab Nouveaux derives de l'acide 3-aminopropanesulfonique ayant une activite membranaire renforcee
US4915685A (en) * 1986-03-19 1990-04-10 Petelenz Tomasz J Methods and apparatus for iontophoresis application of medicaments at a controlled ph through ion exchange
US5602150A (en) * 1992-10-02 1997-02-11 Research Foundation For Mental Hygiene, Inc. Treatment of central nervous system disorders associated with psychotic behavior and dementia with a combination of neuroleptic drugs and taurine, or derivatives thereof, to prevent the development of tardive dyskinesia
US6099869A (en) * 1995-04-18 2000-08-08 Nutrition 21 Calcium taurate and antihypertensive drug for hypertension
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
SI1051393T1 (en) * 1998-01-27 2004-02-29 Merck Sante New derivatives of sulfonic, phosphonic and phosphinic aminoalkane acids, their production and their use as medicaments
JP4726304B2 (ja) * 1999-04-28 2011-07-20 ベルス ヘルス （インターナショナル） リミティッド アミロイドーシスを治療するための組成物および方法
US6562836B1 (en) 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
US6881750B2 (en) * 2003-03-04 2005-04-19 Nutrition Corp. Of America, Ltd. Potassium taurate bicarbonate and ascorbate
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
EP1828111A2 (en) * 2004-11-12 2007-09-05 Neurochem (International) Limited Methods and fluorinated compositions for treating amyloid-related diseases
AU2005310979A1 (en) * 2004-11-16 2006-06-08 Bellus Health (International) Limited Compounds for the treatment of CNS and amyloid associated diseases
FR2878160B1 (fr) * 2004-11-19 2008-07-25 Jean Pierre Durlach Utilisation du n-acetyl-taurinate de magnesium pour la preparation de medicaments inhibiteurs de l'hypersensiblite photique
EP1836161B1 (en) * 2004-12-22 2016-07-20 BHI Limited Partnership Methods and compositions for treating amyloid-related diseases
PL3851447T3 (pl) 2006-10-12 2024-03-04 Bellus Health Inc. Sposoby, związki, kompozycje i nośniki dostarczające kwas 3-amino-1-propanosulfonowy
EP2217564A1 (en) * 2007-09-07 2010-08-18 XenoPort, Inc. Complex pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
US20090082464A1 (en) * 2007-09-07 2009-03-26 Bernd Jandeleit Externally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
TW200932734A (en) * 2007-10-15 2009-08-01 Xenoport Inc Internally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
FR2927809B1 (fr) 2008-02-26 2011-01-14 Tri Inov Nouvelle utilisation de n-acetyl-taurinate de zinc.
RU2453310C1 (ru) * 2010-12-09 2012-06-20 Открытое акционерное общество "Всероссийский научный центр по безопасности биологически активных веществ" (ОАО "ВНЦ БАВ") Средство, обладающее нейропротекторным действием в условиях ишемического поражения мозга и гипоксии, представляющее собой 2-аминоэтансульфонат магния, фармацевтические композиции
FR2973702B1 (fr) 2011-04-08 2013-04-26 Tri Inov N-acetyl-taurinate de zinc pour le traitement du cancer de la prostate
AU2012343935A1 (en) * 2011-11-29 2014-07-03 Basf Se Method for producing and purifying salts of acrylamido-2-methylpropane sulfonic acid
EP3310366A4 (en) 2015-06-17 2019-01-02 Margaret Jean Profet Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne
CN106913561B (zh) * 2015-12-25 2020-12-15 北京乳凝创智生物技术研发中心（有限合伙） 牛磺酸螯合钙在制备经皮吸收制剂中的应用
BE1025644B1 (fr) * 2017-10-13 2019-05-15 Synapharm Industrial Synthesis Compose pour le traitement d'une maladie ou d'un trouble du systeme nerveux central chez un sujet en stimulant et/ou en restaurant la plasticite neuronale
BE1025645B1 (fr) * 2017-10-13 2019-05-15 Synapharm Industrial Synthesis Compose pour le traitement de la neurotoxicite due a l'hyperexcitabilite des recepteurs glutamatergiques ionotropes
EP3738588A1 (en) 2019-05-13 2020-11-18 Margaret Jean Profet Topical and oral formulations comprising taurine and magnesium for use in the treatment of rosacea
EP3738596B1 (fr) 2019-05-16 2022-03-16 Synapharm Industrial Synthesis Composé et composition pour utilisation dans le traitement du syndrome prémenstruel et/ou du trouble dysphorique prémenstruel
MX2021013851A (es) 2019-05-16 2022-01-07 Synapharm Ind Synthesis Compuesto y composicion para el uso en el tratamiento del sindrome premenstrual y/o trastorno disforico premenstrual.
BE1026955B1 (fr) * 2019-06-11 2020-08-04 Synapharm Ind Synthesis Procédé de fabrication de N-acétyl-taurinate de magnésium
RU2731106C1 (ru) * 2019-10-23 2020-08-28 Федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации ФГБОУ ВО ВолгГМУ МЗ РФ Дикалиевая соль N-(4-гидроксибензоил)таурина, обладающая антиагрегантной и антитромботической активностью
RU2730835C1 (ru) * 2019-10-23 2020-08-26 Федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации ФГБОУ ВО ВолгГМУ МЗ РФ Дикалиевая соль N-(3-гидроксибензоил)таурина, обладающая антиагрегантной и антитромботической активностью в сочетании с церебропротективным действием
US11376277B2 (en) 2020-06-01 2022-07-05 Celagenex Research (India) Pvt. Ltd. Synergistic medicinal compositions for treating dysfunctional D-serine signaling
CN119504517B (zh) * 2025-01-22 2025-04-18 浙江天启生化股份有限公司 一种乙酰牛磺酸镁的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3232968A (en) * 1959-12-01 1966-02-01 Gen Aniline & Film Corp Process for preparing n-acyl taurates using hypophosphorous acid as catalyst
US3344174A (en) * 1962-08-21 1967-09-26 Monsanto Co Vicinal acylamido sulfonate compounds
DE1256650B (de) * 1965-08-07 1967-12-21 Dr Dieter Arlt Verfahren zur Herstellung von N-acylierten 2-Amino-alkan-sulfonsaeuren-(1) bzw. von 2-Amino-alkan-sulfonsaeuren-(1)
US3544597A (en) * 1969-06-12 1970-12-01 Rohm & Haas Process for manufacturing sulfonated amides
US3960918A (en) * 1973-06-26 1976-06-01 The Lubrizol Corporation Preparation of esters of amidoalkanesulfonic acids

Also Published As

Publication number Publication date
GR62093B (en) 1979-02-22
SE443781B (sv) 1986-03-10
IT1111455B (it) 1986-01-13
FR2384751B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1979-07-20
NL7803131A (nl) 1978-09-26
DE2810918C2 (de) 1985-06-20
GB1599962A (en) 1981-10-07
JPS6256867B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1987-11-27
JPS53149928A (en) 1978-12-27
ZA781697B (en) 1979-03-28
CA1095930A (en) 1981-02-17
US4267194A (en) 1981-05-12
US4199601A (en) 1980-04-22
OA05914A (fr) 1981-06-30
AT356637B (de) 1980-05-12
ES468201A1 (es) 1978-12-01
CH629479A5 (fr) 1982-04-30
AU523705B2 (en) 1982-08-12
IT7867631A0 (it) 1978-03-22
ATA202878A (de) 1979-10-15
SE7803032L (sv) 1978-09-24
AU3463478A (en) 1979-10-04
FR2384751A1 (fr) 1978-10-20
US4271189A (en) 1981-06-02
DE2810918A1 (de) 1978-09-28

Similar Documents

Publication Publication Date Title
BE865163A (fr) Nouveaux derives de la taurine a activite neuro-musculaire renforcee
PL207337A1 (pl) Sposob wytwarzania pochodnych ftalazyny
BE867093A (fr) Derives du cyclohexane
PL206191A1 (pl) Sposob wytwarzania pochodnych guanidyny
MC1220A1 (fr) Nouveaux derives d'imidazolidine
BE867269A (fr) Derives de thiopropanoylamino-acides
BE868532A (fr) Nouveaux derives de la thiazolidine
BE852741A (fr) Substances polyphenoliques a activite pharmacologique
FR2326198A1 (fr) Nouveaux steroides a activite erythropoietique
PL212223A1 (pl) Sposob wytwarzania pochodnych guanidyny
BE871422A (fr) Production de 2,6-diaminonebularines
BE856695A (fr) Derives de peptides a activite biologique
BE862769A (fr) Nouveaux derives de la piperidine
BE863074A (fr) Nouveaux derives de cycloalcanecarbosanilide a activite herbicide
BE849388A (fr) Nouveaux derives de la spermine a activite bacteriostatique
BE866933A (fr) Nouveaux derives de fortmicine
BE869194A (fr) Production de benzamides heterocycliques
BE862569A (fr) Nouveaux derives de chromones a activite medicamenteuse et leur preparation
BR7808456A (pt) Novos derivados de pirazina
BE846805A (fr) Nouveaux steroides a activite erythropoietique
MC1195A1 (fr) Derives acyles
BE825075A (fr) Nouveaux derives de la 1,2,4-oxdiazoline-5-one a activite fongicide
FR2309218A1 (fr) Nouveaux derives de benzobicyclononene a activite anorexiante
FR2341570A1 (fr) Derives de la piperidine
BR7708589A (pt) Coracao de via ferrea

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: LES LABORATOIRES MERAM

Effective date: 19910331